Antidiabetic Potentials of Ginger, Clove, and Dandelion Plants

Abstract

Diabetes mellitus is a common metabolic disease characterized by impaired insulin secretion, insulin resistance, and chronic hyperglycemia. While pharmacological treatments remain essential, plant-derived products have garnered considerable interest in recent times. This attention stems from their capacity to demonstrate broad biological activity coupled with a generally reduced risk of side effects. This review examines the antidiabetic potential of ginger (Zingiber officinale), clove (Syzygium aromaticum), and dandelion (Taraxacum officinale). Literature findings suggest that these plants may exert hypoglycemic effects through various mechanisms, including suppression of activity α-amylase and α-glucosidase, stimulation of insulin secretion, and reduction of oxidative stress and inflammation. Although results from laboratory studies and animal models are promising, clinical studies are limited. Current data suggest that these plants may play a complementary and supportive role in diabetes management. Extensive human-based investigations are still necessary to verify the long-term safety profile and therapeutic efficacy of these compounds.

Keywords

• Diabetes Mellitus
• Zingiber officinale
• Ginger
• Syzygium aromaticum
• Clove
• Taraxacum officinale

Zencefil, Karanfil ve Karahindiba Bitkilerinin Antidiyabetik Potansiyelleri

Abstract

Diabetes mellitus, insülin sekresyonunda bozulma, insülin direnci ve kronik hiperglisemi ile karakterize yaygın bir metabolik hastalıktır. Farmakolojik tedavilerin yanı sıra bitkisel kaynaklı ürünler, daha az yan etki ve geniş biyolojik etkinlikleri nedeniyle son yıllarda dikkat çekmektedir. Bu derlemede zencefil (Zingiber officinale), karanfil (Syzygium aromaticum) ve karahindiba (Taraxacum officinale) bitkilerinin antidiyabetik potansiyelleri ele alınmıştır. Literatür bulguları, bu bitkilerin α-amilaz ve α-glukozidaz inhibisyonu, insülin sekresyonunun uyarılması, oksidatif stres ve inflamasyonun azaltılması gibi çeşitli mekanizmalarla hipoglisemik etkiler gösterebileceğini ortaya koymaktadır. Laboratuvar çalışmaları ve hayvan modellerinden elde edilen sonuçlar umut verici olmakla birlikte, klinik çalışmalar sınırlıdır. Mevcut veriler bu bitkilerin diyabet yönetiminde tamamlayıcı ve destekleyici bir rol oynayabileceğini göstermektedir. Bununla birlikte, insanlarda güvenilirliğini ve etkinliğini doğrulamak için daha kapsamlı çalışmalara ihtiyaç vardır.

Keywords

• Diabetes Mellitus
• Zingiber officinale
• Ginger
• Syzygium aromaticum
• Clove
• Taraxacum officinale

References

1. Abdulrazaq, N. B., Cho, M. M., Win, N. N., Zaman, R., & Rahman, M. T. (2012). Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats. The British journal of nutrition, 108(7), 1194–1201.
2. Akhtar, M. S., Khan, Q. M., Khaliq, T. (1985) Effects of Portulaca oleracae (Kulfa) and Taraxacum officinale (Dhudhal) in normoglycaemic and alloxan-treated hyperglycaemic rabbits. Journal of Pakistan Medical Association 35(7):207–210.
3. Al-Amin, Z. M., Thomson, M., Al-Qattan, K. K., PeltonenShalaby, R., & Ali, M. (2006). Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition, 96(3), 660–666.
4. Almubayedh, H., Ahmad, R., Naqvi, A. A., Ahmad, N. Ethnopharma cological uses and public knowledge regarding, Cinnamomum zeylanicum in Khobar, Saudi Arabia. Journal of Pharmacy & Bioallied Sciences 2018; 10:159–65.
5. Amin, Mir M., Sawhney, S. S., Jassal, M. M. S. (2013) Qualitative and quantitative analysis of phytochemicals of Taraxacum officinale. Wudpecker Journal of Pharmacy and Pharmacology 2(1):001–005.
6. Amir Rawa, M. S., Mazlan, M. K. N., Ahmad, R., Nogawa, T., Wahab, H. A. Roles of Syzygium in AntiCholinesterase, Anti-Diabetic, Anti-Inflammatory, and Antioxidant: From Alzheimer’s Perspective. Plants 2022, 11, 1476.
7. Asha B., Krishnamurthy, K. H. & Devaru, S. (2011) Evaluation of anti hyperglycaemic activity of Zingiber officinale (Ginger) in albino rats. Journal of Chemical and Pharmaceutical Research 3, 452–456.
8. Badreldin, H. A., Blunden, G., Tanira, M. O., & Nemmar, A. (2008). Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food and Chemical Toxicology, 46(2), 409–420.

9. Bischoff, H. (1994). Pharmacology of alpha-glucosidase inhibition. European Journal of Clinical Investigation, 24(S3), 3–10.
10. Bodeker, G., Ong, C. K., Grundy, C. K., Burford, G., Shein, K. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. World Health Organization, 2005.
11. Chaves de Jesus, P., Silva, D. M. R. R., Moura, P. H. M., Gopalsamy, R. G., Silva, E. E. D., Barreto, M. S., Santos, R. S., Martins, A. Y. S., Almeida, A. G. F., Corrêa, A. K. S., Santana, L. A. M., Hariharan, G., Guimarães, A. G., & Borges, L. P. (2025). The in vitro pharmacokinetics of medicinal plants: A review. Pharmaceuticals, 18, 551.
12. Ch'ng, L. Z., Barakatun-Nisak, M. Y., Zukiman, W. Z. H. W., Abas, F., & Wahab, N. A. (2019). Nutritional strategies in managing postmeal glucose for type 2 diabetes: A narrative review. Diabetes & Metabolic Syndrome, 13, 2339–2345.
13. Chaphalkar, S. R., Spicing up diabetes management: Mediterranean diet’s aromatic herbs lower blood sugar. From: https://www.newsmedical.net/news/20240310/Spicing-up diabetesmanagement-Mediterranean-diets-aromatic-herbs lower-blood-sugar.aspx Accessed: Nov 2024.
14. Chiasson, J. L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002). Acarbose for prevention of type 2 diabetes mellitus: The STOPNIDDM randomised trial. Lancet (North American Edition), 359, 2072–2077.
15. Choi, J., Yoon, K.D., Kim, J. (2018) Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities. Bioorganic & Medicinal Chemistry Letters 28(3):476–481.
16. Davaatseren, M., Hur, H. J., Yang, H.J., et al. (2013) Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food and Chemical Toxicology 58:30–36.
17. Demir, S., Nawroth, P. P., Herzig, S., & Üstünel, B. E. (2021). Emerging targets in type 2 diabetes. Advanced Science, 8, 2100275.
18. Di Napoli, A., Zucchetti, P. (2021). A comprehensive review of the benefits of Taraxacum officinale on human health. Bulletin of the National Research Centre; 45:1–7.
19. Dona, A. C., Pages, G., Gilbert, R. G., Kuchel, P. W. (2010). Digestion of starch: In vivo and in vitro kinetic models used to characterise oligosaccharide or glucose release. Carbohydrate Polymers, 80, 599–617.
20. ElSayed, N. A., Aleppo, G., Aroda, V. R., et al. (2023). Standards of medical care in diabetes—2023. Diabetes Care 46: S1–4.
21. Escudero, N. L., De Arellano, M.L., Fernández, S., Albarracín, G., Mucciarelli, S. (2003). Taraxacum officinale as a food source. Plant Foods for Human Nutrition 58:1–10
22. Fan, M., Zhang, X., Song, H., & Zhang, Y. (2023). Phytochemical composition and biological activities of Taraxacum officinale: A review of antioxidant, antiinflammatory and antidiabetic potential. Molecules, 28(13), 5022.
23. Fonyuy, E. W., Lambert, M. N., Jeppesen, P. B. (2016). The physiological effects of dandelion (Taraxacum officinale) in type 2 diabetes. Review of Diabetic Studies, 13, 113–134.
24. Grieve, M. (1931). A modern herbal. Dover Publications.
25. Guo, H., Zhang, W., Jiang, Y., Wang, H., Chen, G., Guo, M. (2019). Physicochemical, structural, and biological properties of polysaccharides from dandelion. Molecules 24:1485.
26. Güvenç, M. (2023). Diyabet. İKSAD Yayınevi.
27. Haro-González, J. N., Castillo-Herrera, G. A., MartínezVelázquez, M., Espinosa-Andrews, H. (2021). Clove essential oil (Syzygium aromaticum L. Myrtaceae): Extraction, chemical composition, food applications, and essential bioactivity for human health. Molecules 26:6387.
28. Hussain, Z., Waheed, A., Qureshi, R. A., et al. (2004). The effect of medicinal plants of Islamabad and Murree region of Pakistan on insulin secretion from INS-1 cells. Phytotherapy Research 18:1–7 International Diabetes
29. Federation (2025). IDF Diabetes Atlas, 11th Edition.
30. Zhu, J., Chen, H., Song, Z., Wang, X., & Sun, Z. (2018). Effects of Ginger (Zingiber officinale Roscoe) on Type 2 Diabetes Mellitus and Components of the Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled complementary and Trials. Evidence-based alternative medicine: eCAM, 2018, 5692962.
31. Kashtoh, H., & Baek, K. H. (2023). New Insights into the Latest Advancement in α-Amylase Inhibitors of Plant Origin with Anti-Diabetic Effects. Plants (Basel, Switzerland), 12(16), 2944.
32. Kania-Dobrowolska, M., & Baraniak, J. (2022). Edible flowers, leaves, stems, and roots as a source of bioactive compounds in dandelion (Taraxacum officinale) – A review. Foods, 11(5), 731.
33. Kumar, S., Singh, D., Sharma, R. (2022). Recent advances in nutritional composition, phytochemistry and pharmacological activities of Syzygium aromaticum (Clove): A comprehensive review. Plant Foods for Human Nutrition 77:345–359.
34. Kuroda, M., Mimaki, Y., Sashida, Y. (2012). Phenylpropanoids and flavonoids from clove (Syzygium aromaticum) and their antioxidant and antiinflammatory properties. Journal of Agricultural and Food Chemistry 60:9141–9145.
35. Laila, U., Kaur, J., Sharma, K., Singh, J., Rasane, P., Kaur, S., & Bhadariya, V. (2025). Recent advances in medicinal plants for metabolic phytochemistry, disorders: Focus on mechanisms and therapeutic potential. Recent Advances in Food, Nutrition & Agriculture.
36. Li, J., Luo, J., Chai, Y., Guo, Y., Tianzhi, Y., & Bao, Y. (2021). Hypoglycemic and insulin-sensitizing effects of Taraxacum officinale root extract in experimental models. Food Science & Nutrition, 9(4), 2075–2085.
37. Mahluji, S., Attari, V. E., Mobasseri, M., et al. (2013). Effects of ginger on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International Journal of Food Sciences and Nutrition 64:682–686.
38. Mahomoodally, M. F., Aumeeruddy, M. Z., Rengasamy, K. R. R., et al. (2021). Ginger and its active compounds in cancer therapy. Seminars in Cancer Biology 69:140149.
39. Morvaridzadeh, M., Sadeghi, E., Agah, S., et al. (2021). Effect of ginger supplementation on oxidative stress parameters: A systematic review and meta-analysis. Journal of Food Biochemistry 45: e13612. (2014).
40. Mozaffari-Khosravi, H., Talaei, B., Jalali, B. A., Najarzadeh, A. The effect of ginger powder supplementation on insulin resistance and glycemic indices. Complementary Therapies in Medicine 22:916.
41. Murray, R. K., Bender, D. A., Botham, K. M., Kennelly, P. J., Rodwell, V. W. (2018). Harper’s illustrated biochemistry (31st ed.).
42. McGraw-Hill. Harper’s Illustrated Biochemistry Nelson, D. L., Cox, M. M. (2017). Lehninger principles of biochemistry (7th ed.).
43. W.H. Freeman. Lehninger Principles of Biochemistry Nisar, M. F., Khadim, M., Rafiq, M., Chen, J., Yang, Y., & Wan, C. C. (2021). Eugenol: A review of its pharmacological properties and therapeutic applications. Arabian Journal of Chemistry, 14(7), 103272.
44. Paudel, K. R., Orent, J., & Penela, O. G. (2025). Pharmacological properties of ginger (Zingiber officinale): What do meta-analyses say? A systematic review. Frontiers in Pharmacology, 16, 1619655.
45. Pandey, V. K., Srivastava, S., Ashish, Dash, K. K., Singh, R., Dar, A. H., Singh, T., Farooqui, A., Shaikh, A. M., & Kovacs, B. (2023). Clove (Syzygium aromaticum) essential oil: Phytochemistry, biological activities and food applications. Heliyon, 9(10), e20789.
46. Perumal, N., Nallappan, M., & et al. (2022). Synergistic antidiabetic activity of Taraxacum officinale and Momordica charantia polyherbal combination. Biomedicine & Pharmacotherapy, 145, 112401.
47. Petersmann, A., Müller-Wieland, D., Müller, U. A., et al. (2019). Definition, classification and diagnosis of diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 127: S1–S7.
48. Pourmasoumi, M., Hadi, A., Rafie, N., et al. (2018). The effect of ginger supplementation on lipid profile: A systematic review. Phytomedicine 43:28–36.
49. Rahimlou, M., Yari, Z., Hekmatdoost, A., et al. (2020). Ginger supplementation in patients with type 2 diabetes: A systematic review. Phytotherapy Research 34:895–906.
50. Rahul, G., Nandhakumar, E. (2022). A systematic review of five herbal ingredients for the management of diabetes mellitus. Asian Journal of Pharmaceutical and Clinical Research 15:18–23.
51. Rasool, S., Sharma, B. (2014). Taraxacum officinale: A high value less known medicinal plant. Annals of Plant Sciences 3:908–915
52. Ruyati, S. S., & Ruyati, S. (2024). Evaluation of the antidiabetic properties of clove essential oil. Biological Sciences, 4(2).
53. Sales, P. M., Souza, P. M., Simeoni, L. A., Magalhães, P. O., Silveira, D. (2012). α-Amylase inhibitors: A review. Journal of Pharmacy & Pharmaceutical Sciences
54. Salehi, B., Ata, A., Kumar, N. V., Sharopov, F., RamírezAlarcón, K., Ruiz-Ortega, A., Ayatollahi, S. A., Tsouh Fokou, P. V., Kobarfard, F., Zakaria, Z. A., Iriti, M., Taheri, Y., Martorell, M., Sureda, A., Setzer, W. N., Durazzo, A., Lucarini, M., Santini, A., Capasso, R., Ostrander, E. A., Rahman, A.-u., Choudhary, M. I., Cho, W. C., & Sharifi-Rad, J. (2019). Antidiabetic potential of medicinal plants and their active components. Biomolecules, 9, 551.
55. Satman, İ., Ömer, B., Tütüncü, Y., et al. (2013). Twelveyear trends in prevalence of diabetes in Turkish adults (TURDEP-II). European Journal of Epidemiology 28:169–180.
56. Schumacher, J. C., Mueller, V., Sousa, C., Peres, K. K., da Mata, I. R., Menezes, R. C. R., & Dal Bosco, S. M. (2024). The effect of oral supplementation of ginger on glycemic control of patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Clinical Nutrition ESPEN, 63, 615–622.
57. Semwal, R. B., Semwal, D. K., Combrinck, S., Viljoen, A. M. (2015). Gingerols and shogaols: Important nutraceutical principles from ginger. Phytochemistry 117:554–568.
58. Singh, A., Malhotra, S., Subban, R. (2008). Dandelion (Taraxacum officinale)- hepatoprotective herb with therapeutic potential. Pharmacognosy Reviews 2:163167
59. Sivashanmugam, M., Sivakumar, K., Subramanian, S. (2018). Antidiabetic potential of Syzygium aromaticum in diabetic rats. Biomedicine & Pharmacotherapy 108:957–964.
60. Stewart-Wade, S. M., Neumann, S., Collins, L. L., Boland, G. J. (2002). The biology of Canadian weeds. Taraxacum officinale. Canadian Journal of Plant Science :825–853
61. Sözmen K., Ünal B., Capewell S., Critchley J., & O’Flaherty, M. (2015). Predicted prevalence of diabetes in Turkey in 2025 and 2035. Turkish Journal of Public Health 13:1–8
62. Tajik, K. M., Pourrajab, F., & Hekmatimoghaddam, S. (2020). Ginger extract increases GLUT-4 expression preferentially through AMPK pathway. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 1–10.
63. Tavvabi-Kashani, N., Hasanpour, M., Rahimi, V. B., Vahdati-Mashhadian, N., & Askari, V. R. (2024). Toxicological and pharmacokinetic profile of eugenol: Metabolism, safety and bioavailability limitations. Toxicon, 236, 107445
64. Udler, M. S., McCarthy, M. I., Florez, J. C., & Mahajan, A. (2019). Genetic risk scores for diabetes diagnosis and precision medicine. Nature Reviews Endocrinology, 15(10), 635–646.
65. Van, B., Abdalla, A. N., Algarni, A. S., Khalid, A., Zengin, G., Aumeeruddy, M. Z., & Mahomoodally, M. F. (2023). Zingiber officinale Roscoe (Ginger) and its bioactive compounds in diabetes: Systematic review of clinical studies and mechanism of action. Current Medicinal Chemistry.
66. Vitalone, A., Menniti-Ippolito, F., Moro, P., et al. (2011). Suspected adverse reactions associated with herbal products used for weight loss. European Journal of Clinical Pharmacology 67:215–224
67. Xue, Q., Xiang, Z., Wang, S., et al. (2022). Nutritional composition and phytochemistry of Syzygium aromaticum. Frontiers in Nutrition 9:1002147
68. Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., Phillips, R. S. (2003). Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26:1277–1294
69. Zhang, M., Zhao, R., Wang, D., et al. (2021). Ginger and its bioactive components are potential resources for health beneficial agents. Phytotherapy Research 35:711–742
70. Zheng, T., Moss-Pierce, T., Ford, P., Jiang, T. A. (2014). Syzygium aromaticum extract regulates energy metabolism in myocytes. Journal of Medicinal Food 17:1003–1010
71. Zheng, Y., Ley, S. H., Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus. Nature Reviews Endocrinology 14:88–98
72. Zhu, J., Chen, H., Song, Z., Wang, X., & Sun, Z. (2018). Effects of ginger (Zingiber officinale Roscoe) on type 2 diabetes mellitus and components of the metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine, 2018, 5692962.
73. Zulcafli, A. S., Lim, C., Ling, A. P., Chye, S., & Koh, R. (2020). Antidiabetic potential of Syzygium sp.: An overview. Yale Journal of Biology and Medicine, 93, 307–325. 1